AJP - Renal Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 267: F839-F844, 1994;
0363-6127/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amuchastegui, C. S.
Right arrow Articles by Perico, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amuchastegui, C. S.
Right arrow Articles by Perico, N.

AJP - Renal Physiology, Vol 267, Issue 5 839-F844, Copyright © 1994 by American Physiological Society


ARTICLES

Calcitonin gene-related peptide reduces renal vascular resistance and modulates ET-1-induced vasoconstriction

C. S. Amuchastegui, G. Remuzzi and N. Perico
Mario Negri Institute for Pharmacological Research, Bergamo, Italy.

Calcitonin gene-related peptide (CGRP) is a novel polypeptide that exerts important effect on the cardiovascular system through its vasorelaxant properties. We studied in vivo in normal rats the effect of acute administration of CGRP on whole kidney function and showed that the intravenous infusion of the peptide resulted in a fall of blood pressure associated with a marked increase in renal plasma flow (RPF) as well as glomerular filtration rate (GFR). These changes were reversible with discontinuation of CGRP infusion. To evaluate whether the renal hemodynamic responses to the peptide were mediated by endogenous vasodilatory prostaglandins of endothelial origin, animals were preexposed to indomethacin, a cyclooxygenase enzyme inhibitor. Inhibition of prostaglandins synthesis with indomethacin failed, however, to prevent the increase in RPF and GFR observed during CGRP infusion. By contrast, NG-nitro-L-arginine methyl ester (L-NAME), which inhibits the synthesis of nitric oxide, a newly discovered endothelium-derived relaxing factor, completely abolished the renal hemodynamic changes induced by CGRP. Moreover, L-arginine infusion in L-NAME-treated rats restored the renal response to CGRP. We have also shown that systemic infusion of CGRP progressively normalized RPF and GFR that were reduced in response to a bolus intravenous injection of the vasoconstrictor endothelin-1. This indicates that CGRP regulates renal hemodynamics and modulates the deleterious effects of vasoconstrictive substances on the kidney.


This article has been cited by other articles:


Home page
Exp PhysiolHome page
J. Li and D. H. Wang
Role of TRPV1 channels in renal haemodynamics and function in Dahl salt-sensitive hypertensive rats
Exp Physiol, August 1, 2008; 93(8): 945 - 953.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Reslerova and R. Loutzenhiser
Renal microvascular actions of calcitonin gene-related peptide
Am J Physiol Renal Physiol, June 1, 1998; 274(6): F1078 - F1085.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Y. Chai, G. Christopoulos, M. E. Cooper, and P. M. Sexton
Characterization of binding sites for amylin, calcitonin, and CGRP in primate kidney
Am J Physiol Renal Physiol, January 1, 1998; 274(1): F51 - F62.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online